Into this landscape of innovation comes a wave of new blood tests that offer unprecedented ... by identifying amyloid-β plaques or tau tangles in brain tissue after death. The 1990s marked ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

A new blood test may be key to diagnosing ... is likely to be the result of an abnormal build-up of proteins - amyloid and tau - in and around brain cells. In Alzheimer's patients, amyloid ...

Researchers have long relied on cerebrospinal fluid (CSF) biomarkers and positron emission tomography (PET) scans to identify amyloid and tau proteins, hallmarks of the disease. However, these ...

Their findings, published in Brain Communications, suggest that GFAP could serve as a biomarker for stroke and brain injuries, potentially leading to faster and more accurate diagnoses through blood ...

Analysis of blood-based biomarkers may be a reliable method to predict behavioral issues in older populations of Asian ...

As biomarkers, total tau and phosphorylated tau can be detected in brain tissue, cell lysates, cerebrospinal fluid (CSF), and blood samples, but scientists must thoughtfully choose validated assays ...

Although my colleagues and I and many others have published extensively on the amyloid mechanism, my lab was also one of four that discovered the tau protein ... deposits in blood vessels but ...

The research team looked specifically at three potential types of blood markers ... and phosphorylated tau 181 is linked to the buildup of toxic amyloid proteins in the brain, a hallmark of ...

Some were linked to amyloid or tau pathology, including the protein-folding markers SFRP1 and SPON1 ... associated with cerebrovascular dysfunction (e.g., Gomez et al., 2025). Blood Ties. Plasma ...

Alzheimer’s disease is the most common condition that causes problems with memory and thinking skills, which is to say that ...